Literature DB >> 16043649

Coagulation assays.

Shannon M Bates1, Jeffrey I Weitz.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16043649     DOI： 10.1161/CIRCULATIONAHA.104.478222

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  36 in total

1.  Description and Evaluation of the Implementation of a Weight-Based, Nurse-Driven Heparin Nomogram in a Tertiary Academic Medical Center.

Authors:  James W Schurr; Craig A Stevens; Anne Bane; Carol Luppi; Sarah E Culbreth; Amy Leigh Miller; Jean M Connors; Katelyn W Sylvester
Journal:  Clin Appl Thromb Hemost       Date:  2017-08-04       Impact factor: 2.389

2.  Toward development of a point-of-care assay of enoxaparin anticoagulant activity in whole blood.

Authors:  Mario A Inchiosa; Suryanarayana Pothula; Keshar Kubal; Vajubhai T Sanchala; Iris Navarro
Journal:  J Thromb Thrombolysis       Date:  2011-07       Impact factor: 2.300

Review 3.  Novel oral anticoagulants: pharmacology, coagulation measures, and considerations for reversal.

Authors:  Larry R Jackson; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2014-04       Impact factor: 2.300

4.  Venous thromboembolic disease.

Authors:  Michael B Streiff; Paula L Bockenstedt; Spero R Cataland; Carolyn Chesney; Charles Eby; John Fanikos; Patrick F Fogarty; Shuwei Gao; Julio Garcia-Aguilar; Samuel Z Goldhaber; Hani Hassoun; Paul Hendrie; Bjorn Holmstrom; Kimberly A Jones; Nicole Kuderer; Jason T Lee; Michael M Millenson; Anne T Neff; Thomas L Ortel; Judy L Smith; Gary C Yee; Anaadriana Zakarija
Journal:  J Natl Compr Canc Netw       Date:  2011-07-01       Impact factor: 11.908

Review 5.  Considerations for analgosedation and antithrombotic management during extracorporeal life support.

Authors:  Pamela K Burcham; Alan J Rozycki; Erik E Abel
Journal:  Ann Transl Med       Date:  2017-02

6.  The Daniel K. Inouye College of Pharmacy Scripts: Obesity: The Drug Dose Debate.

Authors:  Cherie Chu; Louis Lteif; Nicole Young
Journal:  Hawaii J Med Public Health       Date:  2017-06

Review 7.  Reversal Strategies for NOACs: State of Development, Possible Clinical Applications and Future Perspectives.

Authors:  Steen Husted; Freek W A Verheugt; Willemijn J Comuth
Journal:  Drug Saf       Date:  2016-01       Impact factor: 5.606

8.  Traditional and non-traditional anticoagulation management during extracorporeal membrane oxygenation.

Authors:  Andreas Koster; Edis Ljajikj; David Faraoni
Journal:  Ann Cardiothorac Surg       Date:  2019-01

9.  Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor.

Authors:  Dagmar Kubitza; Angelika Roth; Michael Becka; Abir Alatrach; Atef Halabi; Holger Hinrichsen; Wolfgang Mueck
Journal:  Br J Clin Pharmacol       Date:  2013-07       Impact factor: 4.335

10.  M118, a novel low-molecular weight heparin with decreased polydispersity leads to enhanced anticoagulant activity and thrombotic occlusion in ApoE knockout mice.

Authors:  Subrata Chakrabarti; Lea M Beaulieu; Lara A Reyelt; Mark D Iafrati; Jane E Freedman
Journal:  J Thromb Thrombolysis       Date:  2009-11       Impact factor: 2.300
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.